Abstract
Relapsed/refractory AML patients have a poor prognosis, with CR rates of 1–30%, unless allogeneic hematopoietic stem cell transplantation (HSCT) is an available option [...]
Cite
CITATION STYLE
APA
Pane, F., & Maggio, A. (2014). Abstract Book. Thalassemia Reports, 4(2), 4725. https://doi.org/10.4081/thal.2014.4725
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free